TOP NEWS: GSK, Vir Expand Deal To Include New Influenza Therapies Read More
GSK Starts Respiratory Syncytial Virus Candidate Vaccine Programme Read More
Moody's Affirms GSK's A2 Senior Unsecured Ratings; Outlook Negative Read More
BROKER RATINGS: Exane Raises M&S; HSBC Ups Diploma To Buy Read More
UK Dividends Calendar - Next 7 Days Read More
Novartis's Sandoz To Bolster Antibiotics With GSK Cephalosporin Buy Read More
BROKER RATINGS: Investec Cuts NatWest To Sell; UBS Raises Aggreko Read More
BROKER RATINGS: HSBC And ASOS Raised, DS Smith And Spire Cut Read More
TOP NEWS: GlaxoSmithKline Notes EU Approval For HIV Drug Rukobia Read More
BROKER RATINGS: Flutter Raised To Buy; Fresnillo Lowered To Sell Read More
CureVac To Work With UK Government On Vaccines For Covid Variants Read More
BROKER RATINGS: GlaxoSmithKline Gets Two Downgrades; Prudential Raised Read More
LONDON BRIEFING: Newly Unified Unilever Sets Out Growth Ambitions Read More
LONDON MARKET CLOSE: Rising Oil Majors Help Offset Sinking Glaxo Read More
LONDON MARKET MIDDAY: AstraZeneca And Glaxo Give Markets Vaccine Lift Read More
TOP NEWS SUMMARY: Vaccine Hope From GlaxoSmithKline And AstraZeneca Read More
LONDON MARKET OPEN: Glaxo To Co-Develop Covid Vaccine; Vodafone Rises Read More
LONDON BRIEFING: Glaxo Joins CureVac To Fight Covid-19 Variants Read More
LONDON MARKET PRE-OPEN: GlaxoSmithKline, CureVac Team For Covid-19 Jab Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
